Introduction
Staphylococcal 8-haemolysin, distinguished from other staphylococcal haemolysins by its low specific activity on a wide range of erythrocytes, is inhibited by normal mammalian sera [1, 2] and forms a precipitin line on gel diffusion with normal sera [3, 4] . In human serum a relatively constant level of inhibitor was found [5] and by immunoelectrophoresis, Kantor et al. showed that the inhibitor had the mobility of an a-globulin [4] . However the inhibitor(s) have thus far not been identified and we report here evidence that both a-and/3-1ipoproteins of normal serum inhibit the action of ~-haemolysin.
Methods

Assay of haemolysin and inhibitors
Purification and assay of the 8-haemolysin of Staphylococcus aureus strain NCTC 10345 have been described previously [6] . One haemolytic unit (HUso) was the amount of 5-haemolysin which produced 50% haemolysis after 30 min at 20°C. Haemolysin inhibition titres were carried out by serial doubling dilution of samples in buffer (0.2 ml volumes) in WHO agglutination trays and addition of 6 HUso 6-haemolysin in 0.2 ml buffer. After 30 min incubation at 37°C, 0.2 ml washed 1% cod erythrocytes was added; one haemolysin inhibitory unit (I-II) was tlie * Present address: Department of Pathology, The Veterinary School, University of Glasgow, Scotland. amount of inhibitor which completely prevented lysis after 30 min incubation at 20°C.
Removal of inhibitors from serum
8-Haemolysin (10 mg) was coupled to 1 g CNBractivated Sepharose 4B (Pharmacia, Sweden) as described [7] . For removal of inhibitors from serum 1 g 5-haemolysin-Sepharose was stirred with 0.2 ml serum for 2 h at 37°C and the 8-haemolysinSepharose/inhibitor complex removed by centrifugation (500 ×g, 5 min).
Fractionation of serum
Zonal ultracentrifugation was performed in an MSE BXIV Titanium Zonal rotor with an MSE Superspeed 65 ultracentrifuge. Fresh human serum (20 ml) containing 40% w/w KBr was introduced to the periphery of the rotor after formation of a linear KBr gradient (0--40% w/w in 350/aM EDTA) [8] . After centrifugation (120 000 Xg for 24 h at 18°C) KBr solution (40% w/w in 350 jaM EDTA) was pumped to the periphery of the rotor and 20 ml fractions collected from the centre. The E2soand density of fractions were measured, appropriate fractions were pooled, dialyzed free of KBr, concentrated and the inhibitory titres measured.
Identtfication of serum lipoproteins
Lipoproteins were detected by polyacrylamide gel electrophoresis [9] . Serum components were identified by immunoelectrophoresis [lO] andcrossed (Laurell) immunoelectrophoresis [ 11 ] using 1% agarose and 10% v/v sheep antihuman serum (Wellcome Reagents Ltd., Beckenham, England) in 0.05 M barbitone buffer (pH 8.6) for second dimension immunoelectrophoresis. Precipitin arcs were identified using standard proteins, specific antisera (rabbit anti-human a-lipoprotein and rabbit anti-human/3-lipoprotein) (Behring Ltd., London), by specific staining [12] and by reference to published data [13] . For "Immunocore" polyacrylamide gel electrophoresis (Linton Instruments Ltd., Harlow, England) the centre core of each gel was filled with 1% agarose containing 10% antiserum or 2 mg/ml G-haemolysin.
Phospholipids
Phospholipids (Sigma Chemicals, London) were dispersed in buffer [14] and haemolysin inhibitory activity titrated as described above. Enzyme treatment of lipoproteins and phospholipids with trypsin, pronase and Bacillus cereus phospholipase C (EC 3.1.4.3) (Boehringer Ltd., London) was carried out at 37°C for 30 min.
Results
In preliminary experiments serum components were separated by ammonium sulphate precipitation and chromatography using Sephadex G 150 and Sepharose 6B. Two inhibitory components with approximate molecular weights of >106 and 300 000 daltons respectively were detected and/3-lipoprotein was identified as the high molecular weight inhibitor. G-Haemolysin coupled to Sepharose 4B by CNBr removed most of the inhibitory activity of serum with a concomitant loss of/3-1ipoprotein (Fig. 1) .
To further investigate the role of lipoproteins in inhibition of G-haemolysin, serum was subjected to zonal ultracentrifugation in a KBr gradient to isolate the ~-and/~-lipoprotein fractions. Three peaks were obtained (Fig. 2) ; peaks 1 and 2 were identified as /~-lipoprotein (low density lipoprotein) and ~-lipoprotein (high density lipoprotein) respectively by polyacrylamide gel electrophoresis (Fig. 3) , two-dimensional immunoelectrophoresis and "Immunocore" polyacrylamide gel electrophoresis with specific anti- sera. G-Haemolysin was neutralised by purified/3-lipoprotein and a-lipoprotein; the low inhibitory activity in peak 3 was due presumably to traces of alipoprotein since when this was absent from peak 3 no inhibitory activity was detectable. On "Immunecore" polyacrylamide gel electrophoresis G-haemolysin reacted with both ,v. and/3-1ipoproteins to yield visible precipitates.
To investigate the nature of the reaction between G-haemolysin and serum lipoproteins the lipoproteins were enzymically degraded. The inhibitory activity of purified ct. and/3-1ipoproteins was not diminished by papain or trypsin whereas B. cereus phospholipase C reduced inhibitory activity by 88%. In the latter case G-haemolysin was assayed using human erythrocytes Peak 1,0-40 ml; peak 2,220-340 ml; peak 3,460-700 ml. Fig. 3 . Polyacrylamide gel electrophoresis (11) of Sudan black pre-stained lipoproteins prepared by zonal ultraeentrifugation. P, human serum; 1, 2 and 3, fractions 1,2 and 3 (see Fig. 2) ; B, blank.
since B. cereus phospholipase C was highly haemolytic for cod erythrocytes (25 000 HU/mg), but inactive on human erythrocytes. A wide range of phospholipids inhibited 8-haemolysin and phospholipase C reduced the inhibitory activity of most phospholipids (Table 1) with the exception of sphingomyelin and cardiolipin which have been reported insusceptible to B. cereus phospholipase C [ 15] . 
Discussion
Inhibition of biological activity by lipoproteins has previously been described for streptolysin S [16] and several viruses (e.g. ref. 17) . However, lipoproteins are by no means the only non-immunoglobulin serum factors capable of interaction with f0reifn material as is shown by the activation of the alternative complement pathway by zymosan or endotoxin [18] , the interaction of C-reactive protein with pneumococcal polysaccharide [19] and the conglutinin system. In the present study no evidence was found for inhibition of 8-haemolysin by factors other than lipoproteins.
As shown by Kapral [ 14] phospholipids efficiently inhibited 8-haemolysin; the inability of proteases to degrade inhibitory activity and the effectiveness of B. cereus phospholipase C in reducing the inhibitory activity of both lipoproteins and individual phospholipids indicate that the phospholipid moiety of lipoproteins is probably the combining site of lipoproteins. It is probable that the interaction of 8-haemolysin with membranes results from its affinity for phospholipids. However, the nature of the interaction of 8-haemolysin with phospholipids and any relationship to the staphylococcal phospholipases [20, 21] or to the 7-haemolysin, which also binds to phospholipids [20] , remains to be elucidated.
The identification of lipoproteins as inhibitors present in normal sera and the ability to remove these in a single step are important when considering the immunogenicity of 8-haemolysin [22] [23] [24] .
